"We cannot accept a system where only those with means can benefit from life-changing drugs. We are a wealthy nation that spends trillions on healthcare. We must ensure that income and wealth do not determine access," explained JACC Editor-in-Chief Harlan M. Krumholz, MD.

Prasad, MD, left the agency following a blog post from right-wing pundit Laura Loomer highlighting his progressive political views. However, now less than two weeks later, he returns to his leadership role in vaccine policy.

A new two-year study is focused on the potential of using commercially available fitness trackers to identify patients who may face an increased risk of CVD.

A study analyzing data on 1.2 million children over two decades found no evidence that aluminum ingredients in vaccines cause autism or autoimmune disorders. HHS Secretary Robert F. Kennedy Jr. called the research “deceitful propaganda.”

Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business. 

This is a rapidly growing area of interest in cardiology as research continues to find close links between heart disease and kidney disease.

A new natural language processing tool from Google is being trained on spaceflight scenarios to aid medical personnel on missions to the moon, Mars and beyond.

Tirzepatide and semaglutide are getting the attention now, but orforglipron could be the next go-to drug for patients hoping to lose weight and improve their heart health—no injections required.